Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.15 USD
Change Today +0.01 / 0.88%
Volume 163.2K
ETRM On Other Exchanges
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

enteromedics inc (ETRM) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/2/14 - $2.17
52 Week Low
04/2/15 - $0.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ENTEROMEDICS INC (ETRM)

enteromedics inc (ETRM) Related Businessweek News

No Related Businessweek News Found

enteromedics inc (ETRM) Details

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company’s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. It develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. The company is evaluating the Maestro System in human clinical trials in the United States, Australia, and Mexico. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

28 Employees
Last Reported Date: 03/13/15
Founded in 2002

enteromedics inc (ETRM) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $410.2K
Co-Founder and Vice President of Clinical & R...
Total Annual Compensation: $297.2K
Chief Operating Officer, Chief Financial Offi...
Total Annual Compensation: $338.3K
Senior Vice President of Research & Advanced ...
Total Annual Compensation: $296.6K
Compensation as of Fiscal Year 2014.

enteromedics inc (ETRM) Key Developments

EnteroMedics Inc. Announces Executive Appointments

EnteroMedics Inc. announced that Scott A. Shikora, MD, FACS has been named executive vice president of Medical Affairs and chief medical officer of company, effective June 1, 2015. In this role, he will lead the company's medical affairs, clinical and regulatory functions. Dr. Shikora previously served as company' consulting chief medical officer. The company also announced that Tonya Dowd, MPH, has joined to the company as vice president of Reimbursement, effective April 4, 2015.

EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy

EnteroMedics Inc. announced that the Company has entered into a partnership with American HealthCare Lending to provide funding for patient access to vBloc Therapy, delivered via the Maestro Rechargeable System, for the treatment of obesity. The Maestro System is approved for adults with a BMI of 40 to 45 kg/m2 or a BMI of 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years.

EnteroMedics Inc. Presents at 12th Annual BIO Asia International Conference, Mar-24-2015 04:00 PM

EnteroMedics Inc. Presents at 12th Annual BIO Asia International Conference, Mar-24-2015 04:00 PM. Venue: Grand Hyatt Hotel, Tokyo, Japan.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ETRM:US $1.15 USD +0.01

ETRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ETRM.
View Industry Companies

Industry Analysis


Industry Average

Valuation ETRM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 11.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENTEROMEDICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at